Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) is reporting on its third share buyback program. Between May 11 and May 15, 2026, BBVA executed transactions to repurchase its own shares. The total cash amount spent on these repurchases to date is 218,512,616.00 Euros, which represents approximately 14.97% of the maximum a...

Banco Santander-Chile announced the placement of dematerialized bearer bonds in the local market on May 15, 2026. The bonds, Series AA-14 with ticker BSTD141223, total 140,000 UF and mature on December 1, 2028. The average placement rate was 1.81%. This placement was made under a credit line registered with the CMF Sec...

Banco Santander-Chile reported a material fact regarding the placement of dematerialized bearer bonds in the local market. The placement utilized a credit line registered with the CMF Securities Registry and included Series BG Bonds with the ticker BSTDBG0125. The total amount placed was Ch$ 16,200,000,000 pesos, with ...

BGM Group Ltd has entered into a securities purchase agreement for a private placement of 200,000,000 Class A ordinary shares and warrants to purchase an additional 200,000,000 Class A ordinary shares. The subscription price is US$0.06 per share. The warrants will be exercisable in two tranches at 200% and 250% of the ...

BTQ Technologies Corp. filed a Form 6-K for the month of May 2026, incorporating exhibits that include their condensed interim consolidated financial statements for the three months ended March 31, 2026, and Management's Discussion & Analysis. The financial statements reveal a net loss of $19,927,935 for the period, wi...

Baidu, Inc. announced its unaudited financial results for the first quarter ended March 31, 2026. Key highlights include: Revenue from Baidu Core AI-powered Business reached RMB 13.6 billion, a 49% year-over-year increase, and now constitutes over half of Baidu General Business revenue. Total revenue for Baidu General ...

This filing reports significant changes in the board of directors of Baosheng Media Group Holdings Limited. Sheng Gong and Jianhua Cheng have resigned from their director positions due to personal reasons. Effective May 13, 2026, Lei Cai was appointed as a director to fill the vacancy left by Mr. Gong. Mr. Cai brings e...

BrainsWay Ltd. has entered into a strategic equity financing agreement with APS Innovations LLC, the parent company of Advanced Psychiatric Management LLC (collectively, “Hopemark Health”). BrainsWay will invest an initial $1.5 million, with a potential for an additional $1.5 million through milestone-based investments...

Brenmiller Energy Ltd. announced the appointment of Nir Brenmiller as Chief Executive Officer, effective upon shareholder approval of his and Avi Brenmiller's compensation packages. Avi Brenmiller will continue as Chairman of the Board. Nir Brenmiller, previously Deputy CEO and COO, has been with the company since 2012...

Kingsley Wheaton, Chief Corporate Officer at British American Tobacco p.l.c., sold 781 ordinary shares on May 18, 2026, for an aggregate amount of £38,693.67. The transactions occurred on the London Stock Exchange (XLON). This is an initial notification of the sale of shares....

C3is Inc. reported unaudited financial results for Q1 2026 ending March 31, 2026, showing strong operational performance. The shipping company generated $11.6 million in revenues, a 34% increase year-over-year, with daily Time Charter Equivalent rates rising 98.6% to $32,173. Adjusted net income surged 358% to $5.5 mil...

Chunghwa Telecom Co., Ltd. is announcing its participation in an investor conference hosted by UBS on May 27, 2026, in Hong Kong. The conference will begin at 8:00 am Taipei time. Further details and presentation materials will be available on the company's investor relations websites....

This filing is a communication from Coca-Cola Europacific Partners plc (CCEP) to its shareholders regarding the upcoming Annual General Meeting on May 28, 2026. The company is seeking shareholder support for all resolutions, as recommended by the Board of Directors. Specifically, it provides additional context on Resol...

Compugen reported its first quarter 2026 financial results and provided updates on its clinical pipeline. The company's COM701 MAIA-ovarian trial for platinum-sensitive ovarian cancer is actively enrolling patients across U.S., Israel, and France sites, with an interim analysis on track for Q1 2027. Partner AstraZeneca...

Credicorp Ltd. reported its first-quarter 2026 results, showcasing record-high net income and a 21.1% return on equity (ROE), driven by strong business performance and favorable market conditions. The company saw an 8.2% year-over-year increase in its loan portfolio, led by BCP and Mibanco, while asset quality improved...

On May 18, 2026, Can-Fite BioPharma Ltd. announced the peer-reviewed publication of positive clinical data for its drug candidate Piclidenoson in the treatment of canine osteoarthritis. The article, published in Frontiers in Veterinary Science, validates previously reported findings demonstrating that oral treatment wi...

On May 18, 2026, Clearmind Medicine Inc. announced a new research agreement with Yissum Research Development Company of the Hebrew University of Jerusalem. The partnership will fund a 12-month preclinical study titled "Assessing the Metabolic Efficacy of MEAI in Combination and Sequencing with Tirzepatide in Diet-Induc...

On May 18, 2026, Clearmind Medicine Inc. announced that it entered into an agreement with CLA Investors to issue and sell convertible promissory notes in the aggregate principal amount of $600,000. This transaction is conducted under an existing amendment to securities purchase agreements (SPAs) originally dated Septem...

Concord Medical Services Holdings Limited filed a Form 6-K to report subsequent developments regarding board changes at its subsidiary Concord Healthcare Group Co., Ltd. Mr. Liang Chang resigned as an executive director of Concord Healthcare effective May 11, 2026, due to personal career planning considerations. Concur...

Copa Holdings, S.A. convened its Annual Shareholders Meeting on May 13th, 2026. Key outcomes included the approval of Mrs. Julianne Canavaggio and Mr. Manuel Orillac as independent directors for a two-year term ending in 2028. Additionally, Class B shareholders approved the election of a slate of directors, including t...

Core AI Holdings, Inc. announced its financial results for the fiscal year ending December 31, 2025. The company reported a significant 58.6% year-over-year increase in revenue from continuing operations, reaching $55.2 million in 2025, up from $34.8 million in 2024. This growth reflects expanded operational scale and ...

This filing is a report of foreign private issuer for the month of May 2026, including a notice of annual general meeting of shareholders, notice of availability of proxy materials, and notice of abridgement. The annual general and special meeting will be held virtually on June 22, 2026. Key items for consideration inc...

Dr. Reddy's Laboratories Limited has announced its schedule for upcoming investor meetings and conferences. The company's management will be participating in several group meetings organized by various financial institutions including Elara Capital, Bank of America, Nomura, and Investec. These meetings are scheduled to...

This filing is an amendment to Dr. Reddy's Laboratories Limited's annual report on Form 20-F. It includes an intimation dated May 18, 2026, which contains the transcript of the earnings call held on May 12, 2026, for the quarter and financial year ended March 31, 2026. The transcript is also available on the company's ...

Draganfly Inc. has entered into a definitive asset purchase agreement to acquire substantially all of the assets of Skip Dynamix’s drone technology business. This strategic acquisition aims to integrate Skip Dynamix’s ultra-low-cost, mass-producible fixed-wing unmanned aerial systems into Draganfly’s platform, enhancin...